Literature DB >> 6884387

Reports of two cases of autoimmune thyroiditis while receiving anticonvulsant therapy.

S Nishiyama, M Matsukura, S Fujimoto, I Matsuda.   

Abstract

Two cases, one a 15-year-old girl and the other a 12-year-old girl, with goitrous hypothyroidism associated with elevated anti-DNA and antithyroid antibodies are reported. Abnormalities were noticed 1 year and 3 months and 5 years after the start of anticonvulsant therapy in case 1 and case 2, respectively. Alternation of drug (Valproate from ethosuximide) in case 1 resulted in disappearance of the goitre, and the thyroid function tests became normal. The titers of the antithyroglobulin and the antimicrosomal antibodies were reduced (below 1:100) from 1:400 and 1:1600, respectively. Discontinuance of anticonvulsant therapy and replacement therapy with desiccated thyroid in case 2 resulted in clinical improvement, reduction of antithyroglobulin antibody from 1:6400 to 1:400 and of antimicrosomal antibody from 1:409,600 to 1:25,600, and the thyroid function tests becoming normal. The present observations suggest that the anticonvulsants may induce or exacerbate autoimmune mechanisms in certain thyroid diseases.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6884387     DOI: 10.1007/bf00441656

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  12 in total

1.  Depression of the serum protein-bound iodine level by diphenylhydantion.

Authors:  J H OPPENHEIMER; L V FISHER; K M NELSON; J W JAILER
Journal:  J Clin Endocrinol Metab       Date:  1961-03       Impact factor: 5.958

2.  Thyroid hormone levels and protein binding in patients on long-term diphenylhydantoin treatment.

Authors:  P Heyma; R G Larkins; D Perry-Keene; C T Peter; D Ross; J G Sloman
Journal:  Clin Endocrinol (Oxf)       Date:  1977-05       Impact factor: 3.478

3.  Anticonvulsant-induced antinuclear antibodies and lupus-like disease in children.

Authors:  D H Beernink; J J Miller
Journal:  J Pediatr       Date:  1973-01       Impact factor: 4.406

4.  Decreased serum free thyroxine concentration in patients treated with diphenylhydantoin.

Authors:  W Chin; G C Schussler
Journal:  J Clin Endocrinol Metab       Date:  1968-02       Impact factor: 5.958

5.  Goitre and hypothyroidism in children and adolescents during long-term anticonvulsive therapy.

Authors:  H Krawczyńska; K Wójcik-Musiałek; E Dytkowska; E Małunowicz; A Karkowski; M Chmura
Journal:  Endokrynol Pol       Date:  1979 Sep-Oct       Impact factor: 1.582

6.  [Changes in the thyroid hormone system with combined anticonvulsion treatment of epileptic children and adolescents (author's transl)].

Authors:  H Fichsel; G Knöpfle
Journal:  Klin Padiatr       Date:  1977-03       Impact factor: 1.349

7.  Antinuclear antibodies and lupus-like syndromes in children receiving anticonvulsants.

Authors:  B H Singsen; L Fishman; V Hanson
Journal:  Pediatrics       Date:  1976-04       Impact factor: 7.124

8.  Delayed cutaneous hypersensitivity in children with severe multiple handicaps treated with phenytoin.

Authors:  A Higashi; I Matsuda; S Sinosuka; H Ohtsuka; F Endo; T Maeda; T Ikeda; S Miyoshino
Journal:  Eur J Pediatr       Date:  1978-12-01       Impact factor: 3.183

9.  Increased thyroxine turnover and thyroidal function after stimulation of hepatocellular binding of thyroxine by phenobarbital.

Authors:  J H Oppenheimer; G Bernstein; M I Surks
Journal:  J Clin Invest       Date:  1968-06       Impact factor: 14.808

10.  Association of serum antithyroid antibodies with lymphocytic infiltration of the thyroid gland: studies of seventy autopsied cases.

Authors:  H Yoshida; N Amino; K Yagawa; K Uemura; M Satoh; K Miyai; Y Kumahara
Journal:  J Clin Endocrinol Metab       Date:  1978-06       Impact factor: 5.958

View more
  1 in total

1.  Autoimmune hepatitis and thyroiditis associated with rifampin and pyrazinamide prophylaxis: an unusual reaction.

Authors:  Omar Khokhar; Christopher Gange; Stephen Clement; James Lewis
Journal:  Dig Dis Sci       Date:  2005-01       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.